Li Jinxiao, Chao Xianli, Wang Fengbo, Yuan Xiaowa, Zhang Ming, Xiang Zhaohui
Altern Ther Health Med. 2024 Sep;30(9):256-261.
The primary aim of this research is to investigate the predictive value of subdural effusion thickness in determining the progression of post-traumatic subdural effusion to chronic subdural hematoma. Studying this progression is crucial as it helps in early diagnosis and effective management of chronic subdural hematoma, which is a serious and life-threatening condition. This research is valuable and relevant for improving patient outcomes and reducing the associated risks and complications.
We conducted a retrospective examination of the clinical data obtained from 124 patients who were treated for post-traumatic subdural effusion at our neurosurgery department between March 2017 and March 2021. The data collection process involved reviewing the patients' medical records, radiographic images, and follow-up visits. We used strict criteria for patient selection, including a confirmed diagnosis of post-traumatic subdural effusion, availability of follow-up data, and no prior history of chronic subdural hematoma. Patients who experienced a progression of subdural effusion to chronic subdural hematoma were assigned to the hematoma group (26 cases). In comparison, those who did not show such progression were categorized into the effusion group (98 cases). We endeavored to identify potential risk factors contributing to the progression from subdural effusion to chronic subdural hematoma. The predictive strengths of these risk factors were evaluated using receiver operating characteristic (ROC) curves.
There were no statistically significant disparities between the two groups in terms of gender, hypertension, COPD, and GCS scores (P > .05). However, significant differences were noted in the variables of age, tSAH, the location of subdural effusion, and subdural effusion thickness (P < .05). Multivariate logistic regression analysis disclosed age (1.213), tSAH (12.542), and subdural effusion thickness (1.786) as independent risk factors for the conversion of TSE to CSDH (P < .05). The ROC curve showed the AUC values of age, tSAH, and subdural effusion thickness for predicting CSDH to be 0.739, 0.670, and 0.820, respectively, with a combined AUC value of 0.942, thereby outperforming the individual tests.
In patients suffering from post-traumatic subdural effusion, the thickness of the subdural effusion emerges as a strong predictor for its progression into a chronic subdural hematoma. Clinicians should be particularly cautious when the effusion thickness exceeds 10.7 mm, as the likelihood of transformation increases significantly. These findings have important implications for clinical practice and patient management, highlighting the need for prompt and effective treatment to prevent chronic complications.
本研究的主要目的是探讨硬膜下积液厚度在确定创伤后硬膜下积液进展为慢性硬膜下血肿中的预测价值。研究这种进展至关重要,因为它有助于慢性硬膜下血肿的早期诊断和有效管理,而慢性硬膜下血肿是一种严重且危及生命的疾病。本研究对于改善患者预后、降低相关风险和并发症具有重要价值和意义。
我们对2017年3月至2021年3月在我院神经外科接受创伤后硬膜下积液治疗的124例患者的临床资料进行了回顾性分析。数据收集过程包括查阅患者的病历、影像学图像和随访记录。我们采用严格的患者选择标准,包括确诊为创伤后硬膜下积液、有随访数据且无慢性硬膜下血肿病史。硬膜下积液进展为慢性硬膜下血肿的患者被归入血肿组(26例)。相比之下,未出现这种进展的患者被归入积液组(98例)。我们努力确定导致硬膜下积液进展为慢性硬膜下血肿的潜在危险因素。使用受试者操作特征(ROC)曲线评估这些危险因素的预测强度。
两组在性别、高血压、慢性阻塞性肺疾病(COPD)和格拉斯哥昏迷量表(GCS)评分方面无统计学显著差异(P>.05)。然而,在年龄、创伤性蛛网膜下腔出血(tSAH)、硬膜下积液位置和硬膜下积液厚度等变量上存在显著差异(P<.05)。多因素逻辑回归分析显示年龄(1.213)、tSAH(12.542)和硬膜下积液厚度(1.786)是创伤后硬膜下积液(TSE)转化为慢性硬膜下血肿(CSDH)的独立危险因素(P<.05)。ROC曲线显示,年龄、tSAH和硬膜下积液厚度预测CSDH的曲线下面积(AUC)值分别为0.739、0.670和0.820,联合AUC值为0.942,优于单项检测。
在创伤后硬膜下积液患者中,硬膜下积液厚度是其进展为慢性硬膜下血肿的有力预测指标。当积液厚度超过10.7mm时,临床医生应格外谨慎,因为转化的可能性会显著增加。这些发现对临床实践和患者管理具有重要意义,强调了及时有效治疗以预防慢性并发症的必要性。